Power of metabolomics in biomarker discovery and mining mechanisms of obesity

Obesity Reviews

Volumn 14, Issue 4, 2013, Pages 344-349

  Zhang, A ^a   Sun, H ^a   Wang, X ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Early diagnosis; Metabolites; Metabolomics; Obesity

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHILDHOOD OBESITY; COMORBIDITY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; HUMAN; LIPID METABOLISM; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; QUANTITATIVE ANALYSIS;

BIOMARKERS; EARLY DIAGNOSIS; METABOLITES; METABOLOMICS; OBESITY;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; METABOLOMICS; OBESITY; PHENOTYPE;

EID: 84875050927     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12011     Document Type: Article

References (46)

1. Choi JH, Banks AS, Estall JL etal. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010; 466: 451-456.
2. Henao-Mejia J, Elinav E, Jin C etal. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
3. World Health Organization (WHO). Global Strategy on Diet, Physical Activity and Health. 2011. [WWW document]. URL http://www.who.int/dietphysicalactivity/childhood/en/ (accessed 18 December 2012).
4. Houtkooper RH, Auwerx J. Obesity: new life for antidiabetic drugs. Nature 2010; 466: 443-444.
5. Friedman JM. Obesity: causes and control of excess body fat. Nature 2009; 459: 340-342.
6. Wang X, Zhang A, Han Y etal. Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease. Mol Cell Proteomics 2012; 11: 370-380.
7. Zhang A, Sun H, Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol 2012; 168: 1718-1727.
8. Wang X, Yang B, Sun H, Zhang A. Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal Chem 2012; 84: 428-439.
9. Wang X, Wang H, Zhang A etal. Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res 2012; 11: 1284-1301.
10. Zhang A, Sun H, Han Y etal. Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach. Analyst 2012; 137: 4200-4208.
11. Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion-switching, targeted mass spectrometry- basedmetabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 2012; 7: 872-881.
12. Czupryn A, Zhou YD, Chen X etal. Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice. Science 2011; 334: 1133-1137.
13. Park EJ, Lee JH, Yu GY etal. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010; 140: 197-208.
14. Leslie M. Circadian rhythms. Sleep study suggests triggers for diabetes and obesity. Science 2012; 336: 143.
15. Yuliana ND, Jahangir M, Korthout H, Choi YH, Kim HK, Verpoorte R. Comprehensive review on herbal medicine for energy intake suppression. Obes Rev 2011; 12: 499-514.
16. Pardo M, Roca-Rivada A, Seoane LM, Casanueva FF. Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 2012; 41: 374-383.
17. Zhang A, Sun H, Wu X, Wang X. Urine metabolomics. Clin Chim Acta 2012; 414C: 65-69.
18. Zhang A, Sun H, Wang P, Han Y, Wang X. Modern analytical techniques in metabolomics analysis. Analyst 2012; 137: 293-300.
19. Zhang A, Sun H, Wang X. Serum metabolomics as a novel diagnostic approach for disease: a systematic review. Anal Bioanal Chem 2012; 404: 1239-1245.
20. Wang X, Yang B, Zhang A, Sun H, Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics 2012; 75: 1411-1427.
21. Wang X, Zhang A, Sun H. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS 2012; 16: 414-421.
22. Dong H, Zhang A, Sun H etal. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods. Mol Biosyst 2012; 8: 1206-1221.
23. Zhang A, Sun H, Wang P, Han Y, Wang X. Recent and potential developments of biofluid analyses in metabolomics. J Proteomics 2012; 75: 1079-1088.
24. Fukushima A, Kusano M, Nakamichi N etal. Impact of clock-associated Arabidopsis pseudo-response regulators in metabolic coordination. Proc Natl Acad Sci U S A 2009; 106: 7251-7256.
25. Catchpole GS, Beckmann M, Enot DP etal. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc Natl Acad Sci U S A 2009; 102: 14458-14462.
26. Gjesing AP, Pedersen O. 'Omics'-driven discoveries in prevention and treatment of type 2 diabetes. Eur J Clin Invest 2012; 42: 579-588.
27. Ugarte M, Brown M, Hollywood KA, Cooper GJ, Bishop PN, Dunn WB. Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA). Genome Med 2012; 4: 35.
28. Mihalik SJ, Michaliszyn SF, de las Heras J etal. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care 2012; 35: 605-611.
29. McKillop AM, Flatt PR. Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine. Diabetes Care 2011; 34: 2624-2630.
30. Mintz-Oron S, Meir S, Malitsky S, Ruppin E, Aharoni A, Shlomi T. Reconstruction of Arabidopsis metabolic network models accounting for subcellular compartmentalization and tissue-specificity. Proc Natl Acad Sci U S A 2012; 109: 339-344.
31. Liu JY, Li N, Yang J etal. Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events. Proc Natl Acad Sci U S A 2010; 107: 17017-17022.
32. Park JM, Kim TY, Lee SY. Prediction of metabolic fluxes by incorporating genomic context and flux-converging pattern analyses. Proc Natl Acad Sci U S A 2010; 107: 14931-14936.
33. Wei H, Pasman W, Rubingh C etal. Urine metabolomics combined with the personalized diagnosis guided by Chinese medicine reveals subtypes of pre-diabetes. Mol Biosyst 2012; 8: 1482-1491.
34. Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, Nair KS. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS ONE 2010; 5: e10538.
35. Duggan GE, Hittel DS, Hughey CC, Weljie A, Vogel HJ, Shearer J. Differentiating short- and long-term effects of diet in the obese mouse using (1) H-nuclear magnetic resonance metabolomics. Diabetes Obes Metab 2011; 13: 859-862.
36. Tsutsui H, Maeda T, Min JZ etal. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. Clin Chim Acta 2011; 412: 861-872.
37. Morris C, O'Grada C, Ryan M etal. The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc Nutr Soc 2012; 71: 634-638.
38. Oberbach A, Blüher M, Wirth H etal. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011; 10: 4769-4788.
39. Kim HJ, Kim JH, Noh S etal. Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J Proteome Res 2011; 10: 722-731.
40. Kim JY, Park JY, Kim OY etal. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 2010; 9: 4368-4375.
41. He Q, Ren P, Kong X etal. Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. J Nutr Biochem 2012; 23: 133-139.
42. Wahl S, Yu Z, Kleber M etal. Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts 2012; 5: 660-670.
43. Jung JY, Kim IY, Kim YN etal. 1H NMR-based metabolite profiling of diet-induced obesity in a mouse mode. BMB Rep 2012; 45: 419-424.
44. Kim SH, Yang SO, Kim HS, Kim Y, Park T, Choi HK. 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 2009; 395: 1117-1124.
45. Calvani R, Miccheli A, Capuani G etal. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 2010; 34: 1095-1098.
46. Cohen DA, Babey SH. Candy at the cash register-a risk factor for obesity and chronic disease. N Engl J Med 2012; 367: 1381-1383.